Peer Review History
| Original SubmissionJanuary 27, 2020 |
|---|
|
PONE-D-20-02106 Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): a randomized controlled trial PLOS ONE Dear Mrs Jiskoot, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== The reviewers have highlighted several issues that need to be addressed including the concern over the drop out rate and the bias that may have resulted. ============================== We would appreciate receiving your revised manuscript by May 15 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Stephen L Atkin, MD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files 3. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1 in your text; if accepted, production will need this reference to link the reader to the Table. 4. Thank you for stating the following in the Competing Interests section: "GJ, ADL, AB, RT and JB have nothing to declare. JL has received unrestricted research grants from Ferring, MSD, Merck-Serono, Roche Diagnostics and Euroscreen. He received consultancy fees from the following companies: Euroscreen, Danone-Nutricia, Ferring, Roche Diagnostics, and Titus Healthcare." Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: "This does not alter our adherence to PLOS ONE policies on sharing data and materials.” (as detailed online in our guide for authors http://journals.plos.org/plosone/s/competing-interests). If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared. Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf. Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: http://journals.plos.org/plosone/s/competing-interests [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Results are reported from a clinical study, involving 155 obese women with polycystic ovary syndrome randomized to one of three study arms. It examined the effect of cognitive behavioral therapy lifestyle sessions combined with a healthy diet and physical therapy with or without 9 months additional feedback through SMS compared to care as usual. In women who received lifestyle sessions, depression scores were significantly lower than in controls. Minor revisions: 1- Abstract: Define SMS. 2- Provide more precise p-values, rather than p< 0.05, p<0.01. 3- Line 170: Typographical error: Normality. 4- Line 172: Indicate the underlying covariance structure used in the mixed modeling the criteria for selecting it. 5-Cite the statistical software used for the analysis. 6- State and justify the study’s target sample size with a pre-study statistical power calculation. The power calculation should include: sample size, alpha level (indicating one or two-sided), minimal detectable difference and statistical testing method. 7- Normality is an underlying assumption for applying the Cohen's d statistic. Indicate if the distribution of the deltas (change from baseline to follow-up) for each outcome was normal. 8- As a limitation, discuss the effects of the high drop-out rate. Reviewer #2: The study by Jiskoot et al assess the impact of CBT +/- SMS on emotional wellbeing in women with PCOS who suffer from overweight/obesity. Notes The study is interesting and examines an important topic. The authors have gone into a lot of efforts in designing and providing the CBT + lifestyle programme. The duration of the study is also much longer compared to other CBT studies and the authors deserve praise for that. The study has clearly been hit by difficulty in recruitment and high drop-out rate which is unfortunate. Comments Main concerns. - In the published protocol of the study ( published in Reproductive Health, Jiskoot et al. 2017); weight loss was the primary outcome while mental health was secondary outcome. However, the authors present the data in this paper as if it is a new study with mental health as the primary outcome, and weight loss is hardly mentioned. This is a protocol deviation which needs clarification. - I feel the study will be much better if presented as a whole. Similar to the published protocol. With weight loss as the primary outcome and emotional health as secondary outcome. - Only women who had a BMI > 25 kg/me and wanted pregnancy were included + Large number of drop outs. This affects generalisation of findings. - It is not clear how missing data have been handled in particular around participants who got pregnant during the study. - Data were reported for only some of the time points (baseline, 12 months). It will be better to report data at 3, 6, 9, and 12 months if available. - Data reported do not match all the outcomes included in the protocol. This raises suspicion of selective reporting. Other concerns: Abstract: - Line 34. Please change ‘’obese women with PCOS’’ to ‘’women with PCOS who have overweight/obesity’’. - Line 36. Weight loss is mentioned in the conclusion but there is no mention of weight loss in the results section to justify this statement. It reads‘’the three-component intervention and/or weight loss is the determining factor for the improvements in emotional well-being.’’ Introduction - Line 48. ‘’PCOS women’’. Please change to ‘’women with PCOS’’. The same applies throughout the manuscript. - Line 50. ‘’abnormal amount of cholesterol derived lipids in their blood (dyslipidemia) characterized by high serum levels of triglycerides and low levels of HDL Cholesterol’’. Please rephrase. - Line 60. ‘’non-obese women with PCOS’’. Please change to ‘’women with PCOS without obesity’’. The same applies throughout the manuscript. - Line 100. ‘’overweight and obese women’’. Please change to ‘’women with overweight and obesity’’. Same applies throughout the manuscript. - Line 101. ‘’The aim of the current study was to compare the changes in depression scores in a three-component CBT lifestyle intervention (with or without SMS), with these scores in the control group’’. This does not fit with the study protocol published in Reproductive Health, Jiskoot et al. 2017 where depression was a secondary outcome and weight loss was primary outcome. Methods: - Line 112, 113. Inclusion criteria. ‘’Women diagnosed with Polycystic Ovary Syndrome (PCOS) according to the Rotterdam 2003 consensus criteria and a BMI above 25 kg/m2 and a wish to become pregnant’’. Why only women who wanted to get pregnant were included? Why only women with BMI > 25 kg/m2 were included. Would that have implications on the generalisability of the study findings? - Line113, 114. Exclusion criteria: ‘’pregnancy at baseline or follow-up’’. What about those with underlying mental health problem or on antidepressants? - The inclusion/exclusion criteria paragraph is very small. Are there any other criteria not mentioned in paper? - Study design. Lines 117, 118. ‘’The current study on emotional well-being represents a secondary analysis’’. Needs a bit more clarification. Secondary analysis of what? If this paper is a secondary analysis of another study, this should be made clear from the introduction rather than trying to present the data as a new study? - Can you please clarify what were the study start and end recruitment dates? - Other measures of quality of life were mentioned in the protocol but not reported, e.g PCOSQ, SF-36? Why not? Could these be included. Analysis - Statistics is better reviewed by a statistician. - Can you please explain what is meant by intention to treat analysis in this study? - The three groups were not equal in terms of weight or BMI? Has this been adjusted for? - What happened to weight during the study? - Has weight loss been considered as a mediator? If not why? can you consider it? - Was there any difference in depression between LS+CBT vs. usual care group at baseline? - Can you please clarify the percentage of patients who completed the programme for each questionnaire (BDI/FNAE/RSE). For example, only 46 participants out of 60 completed the BDI questionnaire at baseline in the usual care group. How many of these 46 participants completed the study? - How many attended each visit at 3, 6, 9 and 12 months? - In figure 1. 60 patients were assigned to each treatment group. Only 12 – 17 participants completed the study in each group (70 – 80% drop out). How do you explain the large drop out? How did you deal with missing data on follow up? - In figure 1. More women in the LS+CBT groups got pregnant than the usual care group. How did you manage this data? - Did any study participant receive any treatment to improve fertility? Discussion - Line 237. ‘’Our results suggest that the effect of the three-component intervention and/or weight loss is the determining factor for the improvement in emotional well-being scores’’. There is no mention on weight loss prior to this in the results section? - Lines 291, 292. ‘’Therefore, we believe that a three-component lifestyle program should be accessible for all women with PCOS.’’ How can you justify this statement if all participants in the study wanted pregnancy and had a BMI > 25 kg/m2 - The limitation paragraph, should include comments on drop out, and restricting inclusion to women with BMI >25 kg/m2 who wanted pregnancy. Conclusions: - Line 296. ‘’obese women’’. Please change to ‘’women with obesity’’. Same applies throughout paper. - Line 298. ‘’ Instead, the three-component intervention and/or weight loss is the determining factor for the improvements in emotional well-being.’’ Again weight loss is mentioned in the conclusions but not explained in results? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr Hassan Kahal [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-02106R1 Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): a secondary analysis of a randomized controlled trial PLOS ONE Dear Mrs Jiskoot, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== please address the reviewers comments regarding the spontaneous pregnancy ============================== We would appreciate receiving your revised manuscript by Jun 12 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols Please include the following items when submitting your revised manuscript:
Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. We look forward to receiving your revised manuscript. Kind regards, Stephen L Atkin, MD Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: (No Response) Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: (No Response) Reviewer #2: I Don't Know ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: (No Response) Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: (No Response) Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #2: Dear Professor Atkin, The reviewers have engaged well with the review process and I feel the manuscript is now much clearer. Comments 1. I feel spontaneous pregnancy during the study is an important information and it is worth mentioning it in the manuscript (it was included in the first submission but excluded in revised version). 2. There has been difference in spontaneous pregnancy rates (during study) between the 3 groups (10 in control group, compared to 14 and 16 in the intervention groups). All women participating in the study wanted fertility, was spontaneous pregnancy during the study considered as a mediator/confounder? If not, could it be included? 3. In the baseline data table; the median weight was 84, 89, and 94.5kg in the control, LS, and LS+SMS groups respectively. While the median BMIs were 30.6, 33.5, and 33.5 kg/m2 respectively. I find it strange that the SL+SMS group was 5kg heavier than SL group but with similar BMI. Can this result be double checked? ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Dr Hassan Kahal [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): a secondary analysis of a randomized controlled trial PONE-D-20-02106R2 Dear Dr. Jiskoot, We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements. Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication. Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. With kind regards, Stephen L Atkin, MD Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-02106R2 Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): a secondary analysis of a randomized controlled trial Dear Dr. Jiskoot: I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. For any other questions or concerns, please email plosone@plos.org. Thank you for submitting your work to PLOS ONE. With kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Stephen L Atkin Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .